Rationale on the decision-making process for opicapone's bedtime regimen in Parkinson's disease

Patricio Soares-da-Silva,Amilcar Falcao,Paulo Magalhaes,Ana Santos,Francisco Rocha,Joaquim Ferreira

Proceedings for Annual Meeting of The Japanese Pharmacological Society（2018）

引用 0|浏览2

暂无评分

摘要

Background: Opicapone (OPC), a new once-daily catechol-O-methyltransferase (COMT) inhibitor [1], was shown to be effective in the treatment of motor fluctuations in Parkinson's disease patients receiving levodopa [2, 3].

查看译文

关键词

parkinson,bedtime regimen,opicapone,decision-making decision-making

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要